Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $374,705 (100.0% shares, 0.0% debt)

Holdings (20)

APLS APELLIS PHARMACEUTICALS INC 31.2%

Value ($000) $116,806 Shares 2,583,059 Est. Cost $46.73 Unrealized -2.4%

RCUS ARCUS BIOSCIENCES INC 18.1%

Value ($000) $67,657 Shares 2,669,974 Est. Cost $33.27 Unrealized -26.4%

— CHINOOK THERAPEUTICS INC 11.9%

Value ($000) $44,629 Shares 2,551,703 Est. Cost $16.88 Unrealized —

— HORIZON THERAPEUTICS PUB L 7.0%

Value ($000) $26,321 Shares 330,000 Est. Cost $87.47 Unrealized —

GOSS GOSSAMER BIO INC 6.2%

Value ($000) $23,085 Shares 2,758,069 Est. Cost $9.60 Unrealized -19.3%

CLDX CELLDEX THERAPEUTICS INC NEW 5.5%

Value ($000) $20,527 Shares 761,398 Est. Cost $25.60 Unrealized +13.5%

XBI SPDR SER TR 4.8%

Value ($000) $18,077 Shares 243,400 Est. Cost $77.85 Unrealized —

STOK STOKE THERAPEUTICS INC 2.7%

Value ($000) $10,085 Shares 763,456 Est. Cost $27.91 Unrealized -45.6%

BBIO BRIDGEBIO PHARMA INC 2.3%

Value ($000) $8,478 Shares 933,743 Est. Cost $38.67 Unrealized -78.4%

VERA VERA THERAPEUTICS INC 2.1%

Value ($000) $7,826 Shares 575,000 Est. Cost $15.54 Unrealized +12.3%

ARVN ARVINAS INC 2.0%

Value ($000) $7,513 Shares 178,500 Est. Cost $37.11 Unrealized +35.2%

RNAM AVIDITY BIOSCIENCES INC 1.2%

Value ($000) $4,673 Shares 321,641 Est. Cost $28.99 Unrealized -48.7%

FDMT 4D MOLECULAR THERAPEUTICS IN 1.2%

Value ($000) $4,417 Shares 632,745 Est. Cost $30.23 Unrealized -67.8%

KROS KEROS THERAPEUTICS INC 1.1%

Value ($000) $4,207 Shares 152,249 Est. Cost $49.87 Unrealized -12.0%

Value ($000) $2,259 Shares 199,876 Est. Cost $59.03 Unrealized —

IMVT IMMUNOVANT INC 0.6%

Value ($000) $2,258 Shares 579,061 Est. Cost $7.02 Unrealized -38.4%

— PROMETHEUS BIOSCIENCES INC 0.6%

Value ($000) $2,258 Shares 80,000 Est. Cost $18.26 Unrealized —

IPSC CENTURY THERAPEUTICS INC 0.6%

Value ($000) $2,184 Shares 260,000 Est. Cost $24.92 Unrealized -60.6%

MREO MEREO BIOPHARMA GROUP PLC 0.3%

Value ($000) $1,120 Shares 1,000,000 Est. Cost $1.12 Unrealized —

— AMBRX BIOPHARMA INC 0.1%

Value ($000) $325 Shares 122,800 Est. Cost $19.60 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
APLS	APELLIS PHARMACEUTICALS INC	2,583,059	$116,806	31.2%	$46.73	-2.4%	COM	03753U106
RCUS	ARCUS BIOSCIENCES INC	2,669,974	$67,657	18.1%	$33.27	-26.4%	COM	03969F109
—	CHINOOK THERAPEUTICS INC	2,551,703	$44,629	11.9%	$16.88	—	COM	16961L106
—	HORIZON THERAPEUTICS PUB L	330,000	$26,321	7.0%	$87.47	—	SHS	G46188101
GOSS	GOSSAMER BIO INC	2,758,069	$23,085	6.2%	$9.60	-19.3%	COM	38341P102
CLDX	CELLDEX THERAPEUTICS INC NEW	761,398	$20,527	5.5%	$25.60	+13.5%	COM NEW	15117B202
XBI	SPDR SER TR	243,400	$18,077	4.8%	$77.85	—	S&P BIOTECH	78464A870
STOK	STOKE THERAPEUTICS INC	763,456	$10,085	2.7%	$27.91	-45.6%	COM	86150R107
BBIO	BRIDGEBIO PHARMA INC	933,743	$8,478	2.3%	$38.67	-78.4%	COM	10806X102
VERA	VERA THERAPEUTICS INC	575,000	$7,826	2.1%	$15.54	+12.3%	CL A	92337R101
ARVN	ARVINAS INC	178,500	$7,513	2.0%	$37.11	+35.2%	COM	04335A105
RNAM	AVIDITY BIOSCIENCES INC	321,641	$4,673	1.2%	$28.99	-48.7%	COM	05370A108
FDMT	4D MOLECULAR THERAPEUTICS IN	632,745	$4,417	1.2%	$30.23	-67.8%	COM	35104E100
KROS	KEROS THERAPEUTICS INC	152,249	$4,207	1.1%	$49.87	-12.0%	COM	492327101
NBP	I MAB	199,876	$2,259	0.6%	$59.03	—	SPONSORED ADS	44975P103
IMVT	IMMUNOVANT INC	579,061	$2,258	0.6%	$7.02	-38.4%	COM	45258J102
—	PROMETHEUS BIOSCIENCES INC	80,000	$2,258	0.6%	$18.26	—	COM	74349U108
IPSC	CENTURY THERAPEUTICS INC	260,000	$2,184	0.6%	$24.92	-60.6%	COM	15673T100
MREO	MEREO BIOPHARMA GROUP PLC	1,000,000	$1,120	0.3%	$1.12	—	ADS	589492107
—	AMBRX BIOPHARMA INC	122,800	$325	0.1%	$19.60	—	SPONSORED ADS	02290A102